Entering text into the input field will update the search result below

Zentalis Pharmaceuticals commences proposed public stock offering

Jun. 28, 2021 4:33 PM ETZentalis Pharmaceuticals, Inc. (ZNTL) StockZNTLBy: Preeti Singh, SA News Editor
  • US clinical-stage biopharmaceutical company Zentalis Pharmaceuticals (NASDAQ:ZNTL) has commenced a $150M underwritten public offering of common shares.
  • All common shares issued in the offering will be sold by Zentalis. A 30-day option will be granted to underwriters to purchase up to $22.5M

Recommended For You

More Trending News

About ZNTL Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ZNTL--
Zentalis Pharmaceuticals, Inc.